Sarah Hughes

EVgo touts 5 million Autocharge+ sessions, but for many drivers, the dream of easy public charging is still short-circuited by unreliable hardware.

With the architect of Cox Automotive's empire now on its board, roadside assistance giant Agero is signaling a new ambition to control the entire vehicle experience.

As cyberattacks escalate, Cytactic hires a powerhouse CRO to sell a new vision of resilience. But can an AI platform truly prepare business for the inevitable?

Autonomous AI now executes campaigns and even buys products for consumers. As the CMO becomes a 'Chief Profit Officer,' who is accountable for the machines?

HARMAN sells its DTS unit to Wipro in a $375M deal, shifting 5,600 employees and forging a new strategic alliance with Samsung and Wipro.

As a new wave of miracle drugs fuels a $20B colorectal cancer market, rising incidence and staggering costs raise urgent questions about access and justice.

A private equity-backed firm is offering a 'Fortune 500' toolkit to save local auto shops. But does this empowerment come at the cost of independence?

Building materials giant CRH is spending billions on its own stock. We investigate if this rewards shareholders or signals a retreat from future investment.

The used car retailer touts record profits and slashed debt, but a look beneath the surface reveals a story of centralized control and growing influence.

Changan's flashy Brazil debut with Gisele Bündchen masks a high-stakes play in a market wary of the broken promises of foreign automakers.

A HK$10 billion program is funding a medical revolution. But can AI-driven breakthroughs in health tech overcome the profound challenges of ethics and equity?

Changan's lavish Brazil debut with Gisele Bündchen masks a complex deal with powerhouse CAOA, reshaping Latin America's auto market and its ties to China.

A new AI tool promises to de-risk corporate mergers by measuring human capital. But does quantifying team resilience come at the cost of employee privacy?

GenScript's industry forum signals a pivotal moment for cell and gene therapy. But can the sector overcome manufacturing hurdles, investment risks, and the need for realistic expectations to deliver on its promise?

New research reveals a disconnect between men acknowledging fertility as a shared issue and actually seeking care. Stigma, cost, and fear are key barriers, prompting calls for more inclusive benefits.

A new philanthropic model is emerging, prioritizing quantifiable results over traditional giving. The GitLab Foundation aims for a 100x return on investment, raising questions about accountability and the future of social impact.

GenPrime’s expansion into Singapore and Manila reflects a growing, tech-driven fertility market, but also highlights the urgent need to address declining birth rates and improve access to care in the region.

Overture Life's CE Mark approval for its DaVitri platform signals a shift in assisted reproductive technology. But can automation truly lower costs and improve access to fertility treatment?

Hong Kong-based entrepreneur Dr. James Liang is investing $64 million into a new foundation aiming to reverse declining birth rates through economic support, cultural shifts, and policy research. Can philanthropy solve a demographic time bomb?

New study reveals strong public support for international collaboration, as the Rockefeller Foundation launches a $50M initiative to ‘Build the Shared Future.’ Can this public mandate translate into real policy change?